In the stomach cancer cell lines SGC-7901 and BGC-823 this compound suppresses the PI3K/Akt/mTOR pathway, which causes increase of expression of BECN1, Atg3, Atg5, p53, and p21, increases the LC3-II/LC3-I ratio, and potentiates autophagy [74]
CJC-1295 has no FDA approval at all
Mortality in sickle cell disease
"Copper peptides cause copper toxicity" The Li et al
10.1002/pro.2604 54 HessS.LindeY.OvadiaO.SafraiE.ShalevD
Phase 2/II: Phase 2 awards are often a Follow On application awarded after startups have successfully been awarded a Phase 1 proposal, have achieved the established technical merit of their R&D, and apply and compete successfully for the prototyping and field-testing Phase 2 of their project